Jump to content

Erondu–Cymet syndrome

Edit links
From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by Citation bot (talk | contribs) at 00:43, 7 June 2020 (Add: s2cid. Removed URL that duplicated unique identifier. | You can use this bot yourself. Report bugs here. | Activated by AManWithNoPlan | All pages linked from User:AManWithNoPlan/sandbox2 | via #UCB_webform_linked). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Erondu–Cymet syndrome is a syndrome caused by a translocation on the 21st chromosome.[1] The genetic karyotype for people with this condition is 46, XY, inv(21)(q11.2q22.1). Findings in these patients include hypotension, hypoxemia, seizures, and impairment of cognitive ability.[1] Patients with this condition may have persistent left superior vena cava that drains into the left atrium, as well as pulmonary arteriovenous malformations. Erondu–Cymet syndrome was discovered in 2006 by Ugochi Erondu and Tyler Cymet.[1]

See also

References

  1. ^ a b c Erondu, U. A.; Cymet, T. C. (Winter 2006). "Chromosome 21 abnormalities a review and report of a case of erondu-cymet syndrome". Comprehensive Therapy. 32 (4): 254–260. doi:10.1007/BF02698072. PMID 17898432. S2CID 37968241.


Stub icon

This genetic disorder article is a stub. You can help Wikipedia by expanding it.

Retrieved from "https://en.wikipedia.org/w/index.php?title=Erondu–Cymet_syndrome&oldid=961173086"